These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 22935351)

  • 1. Urinary N-acetyl-β-D glucosaminidase as a surrogate marker for renal function in autosomal dominant polycystic kidney disease: 1 year prospective cohort study.
    Park HC; Hwang JH; Kang AY; Ro H; Kim MG; An JN; In Park J; Kim SH; Yang J; Oh YK; Oh KH; Noh JW; Cheong HI; Hwang YH; Ahn C
    BMC Nephrol; 2012 Aug; 13():93. PubMed ID: 22935351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
    Meijer E; Boertien WE; Nauta FL; Bakker SJ; van Oeveren W; Rook M; van der Jagt EJ; van Goor H; Peters DJ; Navis G; de Jong PE; Gansevoort RT
    Am J Kidney Dis; 2010 Nov; 56(5):883-95. PubMed ID: 20888104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.
    Messchendorp AL; Meijer E; Visser FW; Engels GE; Kappert P; Losekoot M; Peters DJM; Gansevoort RT;
    Am J Nephrol; 2019; 50(5):375-385. PubMed ID: 31600749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.
    Park HC; Kang AY; Jang JY; Kim H; Han M; Oh KH; Kim SH; Noh JW; Cheong HI; Hwang YH; Ahn C
    BMC Nephrol; 2015 Jun; 16():86. PubMed ID: 26092580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Urinary Neutrophil Gelatinase-Associated Lipocalin for Predicting the Severity of Renal Functions in Patients With Autosomal-Dominant Polycystic Kidney Disease.
    Vareesangthip K; Vareesangthip K; Limwongse C; Reesukumal K
    Transplant Proc; 2017 Jun; 49(5):950-954. PubMed ID: 28583565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes.
    Lobato GR; Lobato MR; Thomé FS; Veronese FV
    Braz J Med Biol Res; 2017 Mar; 50(5):e6106. PubMed ID: 28380198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KIM-1 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease: HALT-PKD Results.
    Griffin BR; You Z; Noureddine L; Gitomer B; Perrenoud L; Wang W; Chonchol M; Jalal D;
    Am J Nephrol; 2020; 51(6):473-479. PubMed ID: 32541154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).
    Nakajima A; Lu Y; Kawano H; Horie S; Muto S
    Clin Exp Nephrol; 2015 Dec; 19(6):1199-205. PubMed ID: 25715868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
    Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
    J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary biomarkers in the early detection and follow-up of tubular injury in childhood urolithiasis.
    Taşdemir M; Fuçucuoğlu D; Küçük SH; Erol M; Yiğit Ö; Bilge I
    Clin Exp Nephrol; 2018 Feb; 22(1):133-141. PubMed ID: 28653226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary biomarkers at early ADPKD disease stage.
    Petzold K; Poster D; Krauer F; Spanaus K; Andreisek G; Nguyen-Kim TD; Pavik I; Ho TA; Serra AL; Rotar L
    PLoS One; 2015; 10(4):e0123555. PubMed ID: 25875363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.
    Fu WJ; Xiong SL; Fang YG; Wen S; Chen ML; Deng RT; Zheng L; Wang SB; Pen LF; Wang Q
    Endocrine; 2012 Feb; 41(1):82-8. PubMed ID: 21779943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kidney injury molecule-1 and N-acetyl-β-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome.
    Jungbauer CG; Birner C; Jung B; Buchner S; Lubnow M; von Bary C; Endemann D; Banas B; Mack M; Böger CA; Riegger G; Luchner A
    Eur J Heart Fail; 2011 Oct; 13(10):1104-10. PubMed ID: 21846754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis.
    Raina R; Lou L; Berger B; Vogt B; Do AS; Cunningham R; Vasavada P; Herrmann K; Dell K; Simonson M
    BMC Nephrol; 2016 Feb; 17():22. PubMed ID: 26923419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study.
    Foster MC; Coresh J; Bonventre JV; Sabbisetti VS; Waikar SS; Mifflin TE; Nelson RG; Grams M; Feldman HI; Vasan RS; Kimmel PL; Hsu CY; Liu KD;
    Clin J Am Soc Nephrol; 2015 Nov; 10(11):1956-63. PubMed ID: 26350438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
    Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of urine biomarkers of kidney injury in polycystic kidney disease.
    Parikh CR; Dahl NK; Chapman AB; Bost JE; Edelstein CL; Comer DM; Zeltner R; Tian X; Grantham JJ; Somlo S
    Kidney Int; 2012 Apr; 81(8):784-90. PubMed ID: 22258321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations.
    Spithoven EM; Meijer E; Boertien WE; Sinkeler SJ; Tent H; de Jong PE; Navis G; Gansevoort RT
    Am J Kidney Dis; 2013 Sep; 62(3):531-40. PubMed ID: 23714171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary Biomarkers to Identify Autosomal Dominant Polycystic Kidney Disease Patients With a High Likelihood of Disease Progression.
    Messchendorp AL; Meijer E; Boertien WE; Engels GE; Casteleijn NF; Spithoven EM; Losekoot M; Burgerhof JGM; Peters DJM; Gansevoort RT;
    Kidney Int Rep; 2018 Mar; 3(2):291-301. PubMed ID: 29725632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.